Benzinga

Benzinga Japan

Benzinga

Benzinga Japan

Benzinga

Benzinga Japan
木曜日, 9 03

Inspire Medical Systems Inc

INSPNYSE
Trade with Public
Trade with Public
$63.07
1.552.52%
近くで: Sep 1, 5:00 PM EST
$63.07
1.552.52%
プレマーケット: 4:13 AM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Inspire Medical Systems Financials

Inspire Medical Systems (INSP) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock jumps 14.6% in pre-market trading. #INSP
Avi Kapoor

PRO
Inspire Medical Systems Lowers FY2026 GAAP EPS Guidance from $0.07-$0.62 to $(0.42)-$0.17 vs $0.90 Est

Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $0.07-$0.62 to $(0.42)-$0.17 vs $0.90 analyst estimate..
Benzinga Newsdesk

PRO
Inspire Medical Systems Raises FY2026 Adj EPS Guidance from $0.75-$1.25 to $1.05-$1.45 vs $0.38 Est; Raises FY2026 Sales Guidance from $825.000M-$875.000M to $835.000M-$875.000M vs $843.387M Est

Inspire Medical Systems (NYSE:INSP) raises FY2026 Adj EPS guidance from $0.75-$1.25 to $1.05-$1.45 vs $0.38 analyst estimate. Raises FY2026 sales outlook from $825.000 million-$875.000 million to $835.000
Benzinga Newsdesk

PRO
Inspire Medical Systems Q2 Adj. EPS $0.14 Beats $(0.27) Estimate, Sales $200.581M Beat $194.671M Estimate

Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $(0.27) by 151.85 percent. This is a 58.82 percent decrease over earnings of $0.34 per
Benzinga Newsdesk

Stock Market Today: Dow, S&P 500, Nasdaq Futures Rise As Traders Monitor US-Iran Ceasefire— Duolingo, Pinterest, AMD In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.)
Rishabh Mishra

PRO
Inspire Medical Systems Lowers FY2026 GAAP EPS Guidance from $1.23-$1.81 to $0.07-$0.62 vs $1.63 Est

Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $1.23-$1.81 to $0.07-$0.62 vs $1.63 analyst estimate..
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

Benzinga

Benzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved